Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

OVERPHARMA - PRODUTOS MÉDICOS E FARMACÊUTICOS LDA

NIF 505792362
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €6,144,391 143 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €6,144,391 143 contracts
A2 · Late Publication €2,438,215,431 7,041 contracts
Contract published to BASE more than 10 days after the signing date
LOW €2,438,215,431 7,041 contracts
A5 · Threshold Splitting €15,617,201 268 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €15,617,201 268 contracts
A6 · Low Competition €3,096,573 33 contracts
Only one bidder participated in a competitive procedure
MEDIUM €3,096,573 33 contracts
A9 · Price Overrun €26,935 6 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €9,778 4 contracts
MEDIUM €17,157 2 contracts
A9 · Abnormal Price Reduction €2,937,448,205 4,763 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €2,937,448,205 4,763 contracts
C3 · Missing Mandatory Fields €1,590,030 160 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €1,590,030 160 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

510
€189,864,149
647
€170,383,327
184
€160,691,408
888
€150,921,474
56
€121,214,565
183
€116,733,175
68
€111,385,732
105
€108,015,988
317
€103,930,374
94
€103,663,160
99
€100,329,460
367
€98,632,124
107
€97,616,984
96
€96,883,838
28
€94,520,562
263
€94,100,069
45
€93,645,897
150
€89,547,713
586
€81,119,210
366
€72,119,872
Page 1 of 5 · 87 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 33 contracts

Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11313274 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-19
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11287600 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-14
040109292025 - 1379/2025 Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11301014 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-12
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11277360 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-10
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11267352 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-06
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11262608 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-03-05
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11275442 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-28
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11275429 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-28
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11290459 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-27
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11290467 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-27
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11249430 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction A6 · Low Competition
€198,660 2025-02-25
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11294684 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-24
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11278032 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-24
Ajuste direto para aquisição de A93 - ACIDO AMINOCAPRÓICO [25%; FRS/AMP; IV] e A94 - ACIDO AMINOCAPRÓICO [3G; SAQUETA/ CART].
PT · 11254755 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€198,660 2025-02-13
Aquisição de GEL HIDROACTIVO C/ MEL 40 % (L-MESITRAN SOFT), BISN. (AQ2022/010)
PT · 11054672 · Ao abrigo de acordo-qu...
A6 · Low Competition
€481 2024-11-26
Aquisição de substituto ósseo
PT · 10930727 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A6 · Low Competition
€11,851 2024-09-20
Aquisição de Dispositivo valvular para cirurgia de glaucoma
PT · 10837867 · Ajuste Direto Regime G...
A6 · Low Competition
€6,250 2024-07-25
Agulha Epicraniana e Campo Cirúrgico Estéril 50 x 60
PT · 10790565 · Consulta Prévia
A5 · Threshold Splitting A6 · Low Competition
€4,847 2024-06-18
1BCP20240161 - AQUISIÇÃO DE AGULHAS, SONDAS E TUBOS
PT · 10717032 · Consulta Prévia
A9 · Abnormal Price Reduction A6 · Low Competition
€16,934 2024-05-15
1BCP20240147 - CONTENTORES HERMETICOS 0,5L, 1.5L, 5L E 7.5L
PT · 10725175 · Consulta Prévia
A6 · Low Competition
€46,502 2024-05-10
Implante Drenagem N/Valvulado p/Tratamento Glaucoma
PT · 10716823 · Consulta Prévia
A6 · Low Competition
€39,300 2024-05-07
040101142024-MEDICAMENTOS EXCLUSIVOS - OVERPHARMA
PT · 10893861 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€27,829 2024-04-12
Medicamentos exclusivos Overpharma Prod.Med.Farmacêuticos, Lda
PT · 10674096 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€14,434 2024-04-03
Aq. Dispositivos médicos: Agulhas, cateres, sondas e algálias
PT · 10610218 · Ajuste Direto Regime G...
A6 · Low Competition
€1,805 2024-03-12
Aquisição de BUTILESCOPOLAMINA 20 MG/1 ML SOL INJ FR 1 ML IM IV SC
PT · 10757697 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€0 2024-02-21
61/1805/2024 - Medicamento Ácido acetilsalicílico 1000 mg Pó sol oral Saq
PT · 10698950 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€275 2024-02-20
Contentores
PT · 10921349 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€25,542 2024-02-08
Contentores
PT · 10921353 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction +1
€25,542 2024-02-08
241G000166/13559 - HEMOSTATICOS
PT · 10536295 · Ajuste Direto Regime G...
A6 · Low Competition
€7,755 2024-02-01
VÁRIAS FAMÍLIAS (PLURIANUAL 2024-2026)
PT · 10529637 · Ajuste Direto Regime G...
A6 · Low Competition
€28,868 2024-01-30
AQUISIÇÃO DE MEDICAMENTO ANO 2024
PT · 10527469 · Ajuste Direto Regime G...
A6 · Low Competition
€10,074 2024-01-30
AE/239/2024 Medicamentos Exclusivos
PT · 10574401 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€12,702 2024-01-16
4600014/2024 Consumíveis injector Imagiologia
PT · 10771791 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€34,342 2024-01-02
Overview
Total Value Won
€3,023,562,354
Contracts Won
10,272
Score 349940 · CRITICAL RISK
NIF
505792362
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • F.F. [P-728f]
    Sócio
    since 2025-01-15
  • F.F. [P-728f]
    Sócio
    since 2025-01-28
  • J.A. [P-f5ff]
    Sócio
    since 2025-01-15
  • J.A. [P-f5ff]
    Sócio
    since 2025-01-28
  • L.P. [P-3a5a]
    Sócio
    since 2025-01-15
  • L.P. [P-3a5a]
    Sócio
    since 2025-01-28
  • A.I. [P-7310]
    Gerente
    2022-04-29 → 2024-11-25
  • E.B. [P-a86e]
    Gerente
    until 2022-04-29
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned